S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)
| Autor: | Anna Görög, Savaş Yayli, T Koltai, Martin Shahid, Miklós Sárdy, Dipankar De, K Hervonen, Giuseppe Cianchini, Jane Setterfield, Kossara Drenovska, Marian Dmochowski, C Rose, Soner Uzun, Ágnes Kinyó, Emiliano Antiga, Aikaterini Patsatsi, F Valitutti, Snejina Vassileva, Cassian Sitaru, Marzia Caproni, Teea Salmi, I. Lakos Jukic, Claudio Feliciani, Jernej Dolinsek, Enno Schmidt, Ilma Rita Korponay-Szabó, Angelo V. Marzano |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Final version
Iga deposition medicine.medical_specialty Venereology Consensus business.industry Dermatitis Herpetiformis dermatitis herpetiformis diagnosis therapy MEDLINE Academies and Institutes Guideline Dermatology medicine.disease 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Infectious Diseases Dermatitis herpetiformis medicine Humans 030211 gastroenterology & hepatology business |
| DOI: | 10.1111/jdv.17183 |
| Popis: | Introduction Dermatitis herpetiformis (DH) is a chronic, pruritic, gluten-induced skin disorder characterized by subepidermal granular IgA deposition and a variable degree of enteropathy identical to that seen in coeliac disease. So far, there has been no European consensus about the management of DH. Methods The guidelines were created by small subgroups of a guideline committee consisting of 26 specialists from various medical fields and one patients' representative. The members of the committee then discussed the guidelines and voted for the final version at two consensus meetings. The guidelines were developed under the support of the European Academy of Dermatology and Venereology (EADV) and in collaboration with the European Dermatology Forum (EDF). Results The guidelines summarize evidence-based and expert-based recommendations (S2 level) for the management of DH (see Appendix). Conclusion These guidelines will improve the quality of management of DH and support dermatologists in their diagnostic and therapeutic decisions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|